CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...
BELFAST, Northern Ireland, May 19, 2023 /PRNewswire/ -- PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the ...
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
A groundbreaking study reveals that an AI-based ECG interpretation method outperforms traditional diagnostic techniques in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results